-
Leerink Swann Lowers Sucampo Pharmaceuticals (SCMP) Valuation To $6 - $7
Tuesday, March 16, 2010 - 9:05amLeerink Swann analysts Gary Nachman and Andrew Finkelstein reiterated their Outperform rating for shares of Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) and lowered valuation of the company's shares to $6 - $7 per share. The analysts said that there were uncertainties in the Sucampo Pharmaceuticals...
Read More >>
